(Q34244281)

English

Low-molecular-weight heparin: the optimal duration of prophylaxis against postoperative venous thromboembolism after total hip or knee replacement

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Low-molecular-weight heparin: the optimal duration of prophylaxis against postoperative venous thromboembolism after total hip or knee replacement (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

venous thromboembolism

1 reference

based on heuristic

inferred from title

author name string

Heit JA

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Thrombosis Research

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

V163-73

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiological observations of thrombo-embolic disease during pregnancy and in the puerperium, in 56,022 women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of oral contraceptives and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Venous thromboembolism associated with hip and knee arthroplasty: current prophylactic practices and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Postphlebitic syndrome after hip arthroplasty. 43 patients followed at least 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Does total hip arthroplasty predispose to chronic venous insufficiency?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Late deep venous thrombosis and delayed weightbearing after total hip arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900388-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0049-3848(00)00388-1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34244281&oldid=1587577608"